Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Bokslutskommuniké for Cline Scientific AB (publ), 556867-8238, for the period 1 January - 31 December 2022

Cline Scientific
Download the release

Cline Scientific AB (publ) ("Cline" or the "Company") issues the following bokslutskommuniké for 2022.

July - December 2022
  • Net sales amounted to 0 (0) SEK.
  • Operating profit amounted to 237,140 (-143,519) SEK
  • Profit per average number of shares after tax amounted to 0.01 (-0.01)
January - December 2022
  • Net sales amounted to 0 (3,991) SEK.
  • Operating profit amounted to -2,317,061 (-3,503,694) SEK
  • Profit per average number of shares after tax amounted to -0.15 (-0.24)

The report is published at www.clinescientific.com/financial-reports

 The company is listed on the Nasdaq First North Growth Market. Redeye AB is Cline Scientific's Certified Adviser. The information was submitted for publication via the contact person listed above, at 8.30am CET on 17 February 2023.

For more information, please contact:

Patrik Sundh, CEO

Email: patrik.sundh@clinescientific.com

Phone: +46 703-585088

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.